z-logo
open-access-imgOpen Access
Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer
Author(s) -
Lihua Zhang,
Yan Wang,
Qianqian Fan,
Yankui Liu,
Longhai Li,
Xiaowei Qi,
Yong Mao,
Hua Dong
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i38.5814
Subject(s) - immunohistochemistry , cancer research , oncology , cancer , biology , clinical significance , western blot , gene knockdown , medicine , apoptosis , gene , biochemistry
Wnt1-inducible signaling pathway protein 1 (WISP1) is upregulated in several types of human cancer, and has been implicated in cancer progression. However, its clinical implications in gastric cancer (GC) remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here